User:Bertoniangelina/sandbox

This is the user sandbox of Bertoniangelina. A user sandbox is a subpage of the user's user page. It serves as a testing spot and page development space for the user and is not an encyclopedia article. Create or edit your own sandbox here.

Other sandboxes: Main sandbox | Template sandbox

Finished writing a draft article? Are you ready to request review of it by an experienced editor for possible inclusion in Wikipedia? Submit your draft for review!

Medicinal Use

P. incarnata is used to treat anxiety, nervousness, insomnia, asthma and ADHD. Some side effects has been reported, like dizziness, confusion and nausea ^[1]. Methanol extractions from the leaves has been reported to be an effective antitussive in mice ^[2] and are effective to treat anxiety ^[3] .

The plant can be used to treat Diabetes mellitus as the extractions of leaves contain high hypergylcemic activity by lowering the blood glucose level ^[4].

Substances

The main substances in P. incarnata are flavonoids, but also alkaloids and other phyto-constituents can be found.

Flavonoids are the main component in P. incarnata. They can reach up to 2.5% of the total content. The greatest concentration of flavonoids has been reported to be in the leaves. Following flavonoids can be found in P. incarnata: chrysin, apigenin, luteolin, quercetin, kaempferol and isovitexin ^[5]. The flavonoid chrysin is thought to be the main substance responsible for the sedative effect of P. incarnata. The anxiety-reducing property is caused by the binding of chrysin to GABA-Benzodiazepinreceptors ^[6]. Little amounts of alkaloids has been reported in P. incarnata (<0.005%). Examples for alkaloids are: harmol, harmine, harmalol ^[7]. Other substances existing in P. incarnata includes mono- and polysaccharids, amino acids and essential oils ^[8].

^ Rodriguez-Fragoso, L., Reyes-Esparza, J., Burchiel, S. W., Herrera-Ruiz, D., & Torres, E. (2008). Risks and benefits of commonly used herbal medicines in Mexico. Toxicology and Applied pharmacology, 227(1), 125-135
^ Dhawan, Kamaldeep, and Anupam Sharma. "Antitussive activity of the methanol extract of Passiflora incarnata leaves." Fitoterapia 73.5 (2002): 397-399.
^ Dhawan, K., Kumar, S., & Sharma, A. (2001). Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia, 72(8), 922-926.
^ Gupta, R. K., Kumar, D., Chaudhary, A. K., Maithani, M., & Singh, R. (2012). Antidiabetic activity of Passiflora incarnata Linn. in streptozotocin-induced diabetes in mice. Journal of ethnopharmacology, 139(3), 801-806.
^ Dhawan, K., Dhawan, S., & Sharma, A. (2004). Passiflora: a review update. Journal of Ethnopharmacology, 94(1), 1-23.
^ Peter, H., & Penzel, T. (2007). Enzyklopädie der Schlafmedizin. Berlin Heidelberg New York Tokio: Springer.)
^ Dhawan, K., Dhawan, S., & Sharma, A. (2004). Passiflora: a review update. Journal of Ethnopharmacology, 94(1), 1-23.
^ Krenn, L. (2006). Aktuelles über Passiflora incarnata. Zeitschrift für Phytotherapie, 27(01), 47-50.

[1] Rodriguez-Fragoso, L., Reyes-Esparza, J., Burchiel, S. W., Herrera-Ruiz, D., & Torres, E. (2008). Risks and benefits of commonly used herbal medicines in Mexico. Toxicology and Applied pharmacology, 227(1), 125-135

[2] Dhawan, Kamaldeep, and Anupam Sharma. "Antitussive activity of the methanol extract of Passiflora incarnata leaves." Fitoterapia 73.5 (2002): 397-399.

[3] Dhawan, K., Kumar, S., & Sharma, A. (2001). Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia, 72(8), 922-926.

[4] Gupta, R. K., Kumar, D., Chaudhary, A. K., Maithani, M., & Singh, R. (2012). Antidiabetic activity of Passiflora incarnata Linn. in streptozotocin-induced diabetes in mice. Journal of ethnopharmacology, 139(3), 801-806.

[5] Dhawan, K., Dhawan, S., & Sharma, A. (2004). Passiflora: a review update. Journal of Ethnopharmacology, 94(1), 1-23.

[6] Peter, H., & Penzel, T. (2007). Enzyklopädie der Schlafmedizin. Berlin Heidelberg New York Tokio: Springer.)

[7] Dhawan, K., Dhawan, S., & Sharma, A. (2004). Passiflora: a review update. Journal of Ethnopharmacology, 94(1), 1-23.

[8] Krenn, L. (2006). Aktuelles über Passiflora incarnata. Zeitschrift für Phytotherapie, 27(01), 47-50.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]